![Meng Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/09/2026
Meng Yu is currently the Chief Operating Officer & Executive Director at Hightide Therapeutics, Inc., a position held since 2015.
Ms. Yu completed undergraduate studies at the University of Science & Technology of China and graduate studies at the School of Medicine University of Nevada.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/04/2026 | 3.744.699 ( 0,56 % ) | 2 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hightide Therapeutics, Inc.
 Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
School of Medicine University of Nevada
 School of Medicine University of Nevada Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
